MORN 最新10-Q变化

相对上期新增的文字 · 来源:10-Q · 2026-07-29

• To supplement our interim consolidated financial statements presented in accordance with US Generally Accepted Accounting Principles (GAAP), we use the following non-GAAP measures:

• Revenue by typeThree months ended June 30,Six months ended June 30,

• (1) Corporate and All Other provides a reconciliation between revenue from our Total Reportable Segments and consolidated revenue amounts. Corporate and All Other includes Morningstar Sustainalytics and Morningstar Indexes as sources of revenues. Revenue from Morningstar Sustainalytics was $25.5 mil…

• In the second quarter of 2026, consolidated revenue increased 9.6% to $663.2 million. Foreign currency movements increased revenue by $3.5 million.

• License-based revenue increased 6.2%, or 3.1% on an organic basis, during the second quarter of 2026, primarily driven by demand for Morningstar Direct Platform and PitchBook products.

相对上期删除的文字 · 来源:10-Q · 2026-04-29

• Cash provided by (used for) financing activities$316.9 $(24.1)NMF

• To supplement our consolidated financial statements presented in accordance with US Generally Accepted Accounting Principles (GAAP), we use the following non-GAAP measures:

• (1) Corporate and All Other provides a reconciliation between revenue from our Total Reportable Segments and consolidated revenue amounts. Corporate and All Other includes Morningstar Sustainalytics and Morningstar Indexes as sources of revenues. Revenue from Morningstar Sustainalytics was $26.6 mil…

• In the first quarter of 2026, consolidated revenue increased 10.8% to $644.8 million. Foreign currency movements increased revenue by $13.5 million.

• License-based revenue increased 6.4%, or 2.6% on an organic basis, during the first quarter of 2026, primarily driven by strong demand for Morningstar Direct Platform and PitchBook products.

相对上期新增的文字 · 来源:10-Q · 2026-07-29

• The adoption and use of AI technologies, whether incorporated into or accessing our products and tools or implemented by third parties, may present business, legal, compliance, and reputational risks.

• We use, and may expand our use of, AI technologies across our products, internal tools, and third‑party SaaS platforms. While AI offers opportunities to improve efficiency and innovation, it also introduces risks. If we fail to keep pace with AI advancements, or if competitors adopt AI more effectiv…

• The pace of adoption and use of AI technologies, including generative AI, in our products and processes and by our clients and end users may increase compliance obligations, regulatory scrutiny, litigation exposure, ethical concerns, and confidentiality or security risks. For example, AI systems may…

• AI technologies may use or incorporate data from third-party sources, which may expose us to risks associated with data rights and protection and may also lead to the unintended consequences of using AI discussed above. Also licensing permissions, permitted-use restrictions, ownership of outputs or …

• In addition, the implementation of AI technologies by competitors and disruptors presents risks to our business. The value of our products and services may be negatively affected by the increasing amount of information and external tools that are available online for free, or at low cost, that use A…

相对上期新增的文字 · 来源:10-Q · 2026-07-29

• During the three months ended June 30, 2026, certain of the company's executive officers and directors adopted or terminated a "Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K of the Exchange Act, as noted below:

• Sale of up to 200,000 shares of common stock pursuant to a Rule 10b5-1 trading arrangement

• (1) Each listed trading plan is intended to satisfy the affirmative defense of Rule 10b5-1(c).

• (2) The trading plan may also expire on such earlier date as all transactions under the trading plan are completed.

相对上期删除的文字 · 来源:10-Q · 2026-04-29

• During the three months ended March 31, 2026, none of the company’s officers (as defined in Section 16 of the Exchange Act) and directors adopted or terminated contracts, instructions, or written plans for the purchase or sale of the company’s securities.